secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2026-05-08T23:59:59+00:00
Accession:  0001437749-26-015749
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q1 revenue $47.4M, GAAP EPS -$0.03; backlog record $115.1M
--------------------------------------------------------------------

- Revenue $47.4M, down 6.5% YoY; Battery & Energy sales -4.7%, Communications Systems -25.7%.
- GAAP net loss ($0.5M) or ($0.03) per share vs $1.9M/$0.11 prior year; adjusted EBITDA $3.2M vs $5.4M.
- Gross margin 21.3% (down from 25.1%); operating loss ($0.2M) including $1.7M one-time costs from power outage, inventory integration, and weather.
- Backlog record $115.1M, highest ever, up from $110.2M at Q4 2025 and $95.0M at Q1 2025.
- Management focusing on improving manufacturing efficiencies and driving orders to restore profitability and generate cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774926015749/0001437749-26-015749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774926015749/ulbi20260507_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-015749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer